Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MTTT for Malaria Prevalence in Ghana
NCT04301531Completed
- Sponsor
- Noguchi Memorial Institute for Medical Research
- Start
- Mar 2020
- Primary completion
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of artemether + lumefantrine in malaria (2 arms), sponsored by Noguchi Memorial Institute for Medical Research. Primary endpoint: Malaria prevalence in children at 2 years. Started Mar 2020; status: completed.
02
Drugs
artemether + lumefantrine
03
Conditions
malaria
Beyond the preview
Go deeper on NCT04301531.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04301531.